https://www.selleckchem.com/pr....oducts/gsk-3484862.h
At present, there is insufficient robust evidence supporting the clinical use of tDCS to alleviate symptoms of neglect. Future research would benefit from careful study design, enhanced precision of electrical montages, multi-modal approaches exploring predictors of response, tailored dose-control applications and increased efforts to evaluate standalone tDCS versus its incorporation into combination therapy.Sub-Saharan Africa is a region that is severely affected by the HIV and AIDS pandemic with females disproportionately affected
Like
Comment
Share
